Research ArticleArticle
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
ALLAN GIBOFSKY, WILLIAM R. PALMER, EDWARD C. KEYSTONE, MICHAEL H. SCHIFF, JINGYUAN FENG, PETER McCROSKERY, SCOTT W. BAUMGARTNER and JOSEPH A. MARKENSON
The Journal of Rheumatology January 2011, 38 (1) 21-28; DOI: https://doi.org/10.3899/jrheum.100347
ALLAN GIBOFSKY
WILLIAM R. PALMER
EDWARD C. KEYSTONE
MICHAEL H. SCHIFF
JINGYUAN FENG
PETER McCROSKERY
SCOTT W. BAUMGARTNER
REFERENCES
- 1.↵
- Akobeng AK
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- Fautrel B,
- Guillemin F,
- Meyer O,
- de Bandt M,
- Berthelot JM,
- Flipo RM,
- et al.
- 9.↵
- 10.↵Enbrel® (etanercept) prescribing information. Immunex Corp., Thousand Oaks, CA, USA.
- 11.↵
- Gibofsky A,
- Palmer WR,
- Goldman JA,
- Lautzenheiser RL,
- Markenson JA,
- Weaver A,
- et al.
- 12.↵
- Weaver AL,
- Lautzenheiser RL,
- Schiff MH,
- Gibofsky A,
- Perruquet JL,
- Luetkemeyer J,
- et al.
- 13.↵
- 14.↵
- 15.↵
- Maury E,
- Hochberg M,
- Cassell S,
- Kavanaugh A,
- Kremer J,
- Reed G,
- et al.
- 16.↵
- Kievit W,
- Creemers MC,
- Fransen J,
- Kuper IH,
- van de Laar MAFJ,
- Jansen TL,
- et al.
- 17.↵
- Dixon WG,
- Watson K,
- Lunt M,
- Hyrich KL,
- Silman AJ,
- Symmons DP
- 18.↵
- 19.↵
- Kremer JM,
- Lavelle L,
- Hinkle K,
- Reed G
- 20.↵
- Askling J,
- Raaschou P,
- van Vollenhoven R,
- Jacobsson L,
- Geborek P,
- Feltelius N,
- et al.
- 21.↵
- Watson KD,
- Dixon WG,
- Hyrich KL,
- Lunt M,
- Symmons DP,
- Silman AJ
- 22.↵
- Maury EE
- 23.↵
- Strangfeld A,
- Zink A,
- Rau R,
- Burmester GR,
- Bungartz C,
- Wilden E,
- et al.
- 24.↵
- Geborek P,
- Bladstrom A,
- Turesson C,
- Gulfe A,
- Petersson IF,
- Saxne T,
- et al.
- 25.↵
- 26.↵
- Mariette X,
- Tubach F,
- Ravaud P,
- Berthelot JM,
- Shaeverbeke T,
- Bardet M,
- et al.
In this issue
The Journal of Rheumatology
Vol. 38, Issue 1
1 Jan 2011
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
ALLAN GIBOFSKY, WILLIAM R. PALMER, EDWARD C. KEYSTONE, MICHAEL H. SCHIFF, JINGYUAN FENG, PETER McCROSKERY, SCOTT W. BAUMGARTNER, JOSEPH A. MARKENSON
The Journal of Rheumatology Jan 2011, 38 (1) 21-28; DOI: 10.3899/jrheum.100347
Rheumatoid Arthritis Disease-modifying Antirheumatic Drug Intervention and Utilization Study: Safety and Etanercept Utilization Analyses from the RADIUS 1 and RADIUS 2 Registries
ALLAN GIBOFSKY, WILLIAM R. PALMER, EDWARD C. KEYSTONE, MICHAEL H. SCHIFF, JINGYUAN FENG, PETER McCROSKERY, SCOTT W. BAUMGARTNER, JOSEPH A. MARKENSON
The Journal of Rheumatology Jan 2011, 38 (1) 21-28; DOI: 10.3899/jrheum.100347